A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

January 13, 2027

Study Completion Date

January 13, 2027

Conditions
Solid TumorsAdvanced Solid TumorsMetastatic Solid Tumors
Interventions
DRUG

INCA33890

INCA33890 will be administered at protocol defined dose.

DRUG

bevacizumab

Bevacizumab will be administered at protocol defined dose.

DRUG

FOLFIRI

FOLFIRI will be administered at protocol defined dose.

DRUG

FOLFOX

FOLFOX will be administered at protocol defined dose.

DRUG

Cetuximab

Cetuximab will be administered at protocol defined dose.

Trial Locations (36)

10016

NOT_YET_RECRUITING

Laura and Isaac Perlmutter Cancer Center, New York

11501

NOT_YET_RECRUITING

Nyu Langone Health - Long Island Hospital, Mineola

19104

NOT_YET_RECRUITING

University of Pennsylvania, Philadelphia

20089

RECRUITING

Irccs Istituto Clinico Humanitas, Rozzano

20133

RECRUITING

Fondazione Irccs Istituto Nazionale Dei Tumori, Milan

28040

RECRUITING

Fundacion Jimenez Diaz University Hospital, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28050

RECRUITING

Centro Integral Oncologico Clara Campal, Madrid

37134

RECRUITING

Centro Ricerche Cliniche Di Verona, Verona

49546

RECRUITING

Cancer and Hematology Centers of Western Michigan-Start Midwest, Grand Rapids

69373

RECRUITING

Centre Leon Berard, Lyon

77030

RECRUITING

University of Texas Md Anderson Cancer Center, Houston

78229

RECRUITING

South Texas Accelerated Research Therapeutics, San Antonio

90025

RECRUITING

The Angeles Clinic and Research Institute, Los Angeles

90067

RECRUITING

Valkyrie Clinical Trials, Los Angeles

94805

RECRUITING

Institut Gustave Roussy, Villejuif

02215

RECRUITING

Dana Farber Cancer Institute, Boston

07601

RECRUITING

Hackensack University Medical Center, Hackensack

02903

RECRUITING

Lifespan Cancer Research Institute, Providence

02100

RECRUITING

Rigshospitalet Uni of Hospital of Copenhagen, Copenhagen

02730

RECRUITING

Herlev Og Gentofte Hospital, Herlev

05000

RECRUITING

Odense University Hospital, Odense C

07100

RECRUITING

Vejle Hospital, Vejle

573-1191

RECRUITING

Kansai Medical University Hospital, Hirakata

135-8550

RECRUITING

The Cancer Institute Hospital of Jfcr, Kōtoku

104-0045

RECRUITING

National Cancer Center Hospital, Tokyo

08023

RECRUITING

Start Barcelona, Barcelona

08035

RECRUITING

Hospital General Universitario Vall D Hebron, Barcelona

06500

RECRUITING

Istituto Oncologico Della Svizzera Italiana, Bellinzona

01011

RECRUITING

Centre Hospitalier Universitaire Vaudois (Chuv), Lausanne

09007

RECRUITING

Kantonsspital St. Gallen, Sankt Gallen

CB2 0QQ

RECRUITING

Cambridge University Hospitals Nhs Foundation Trust, Cambridge

SE1 9RT

RECRUITING

Guys and St Thomas Nhs Foundation Trust, London

W12 0HS

RECRUITING

Imperial College Healthcare Nhs Trust - Hammersmith Hospital, London

M20 4BV

RECRUITING

The Christie Nhs Foundation Trust Uk, Manchester

NE7 7DN

RECRUITING

Freeman Hospital Newcastle Upon Tyne Foundation Nhs Trust, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY